SK-N-BE(2) is a neuroblastoma cell line that displays MYCN amplification. These cells have moderate dopamine-b-hydroxylase activity and low-choline acetyltransferase activity. The SK-N-BE(2) cells are known to form tumours in immunocompromised mice.
Gender:
Male
Additional notes:
The cells exhibit moderate levels of dopamine beta hydroxylase activity. SK-N-BE(2) cells have a reported saturation density greater than 1 X 106 cells/cm2. The morphology of the cells varies with some cells having long processes and others that are epithelioid like. The cells will aggregate, form clumps and float.
Cellosaurus ID:
CVCL_0528
Model description:
Tumourigenic; an inoculum of 107 cells produced tumours in cortisonised hamster cheek pouches with 18% frequency
Products or characteristics of interest:
Karyotype: modal number = 44; one or more HSR bearing chromosomes
Cat. #:
161921
Cancer types:
Neuroblastoma
Organism:
Human
Tissue:
Brain
Gender:
Male
Model:
Tumourigenic
Morphology:
Neuroblast
Growth properties:
Mixed: adherent and suspension
Cancer Types In Detail:
Neuroblastoma
Primary citation:
Biedler et al. 1976. Journal of the National Cancer Institute. 57: 683-695. PMID: 62055.
Storage conditions:
Vapor phase of liquid nitrogen
Shipping conditions:
Dry Ice
Growth medium:
1:1 mixture of EMEM:F12 Medium, then supplemented with FBS to a final concentration of 10%
Temperature:
37° C
Atmosphere:
5% CO2 in air
Storage medium:
Complete growth medium supplemented with 5% (v/v) DMSO
Biosafety level:
1
References:
Barnes et al. 1981. In Vitro. 17: 619-131. PMID: 7327593.
Biedler et al. 1976. Science. 191: 185-187. PMID: 942798.
Biedler et al. 1978. Cancer Research. 38: 3751-3757. PMID: 29704.
Human buccal mucosa modeling; Permeability, absorption and metabolism studies of various substances and enzymatically labile drugs; Drug delivery studies
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.